WO2017119565A1 - 물리적으로 초미세분쇄 홍삼분말을 제조하는 장치와 생화학적 발효, 효소분해를 통한 홍삼 유효성분의 소화 흡수 극대화를 위한 통홍삼 분말 농축액 및 통홍삼액 제조 방법 - Google Patents
물리적으로 초미세분쇄 홍삼분말을 제조하는 장치와 생화학적 발효, 효소분해를 통한 홍삼 유효성분의 소화 흡수 극대화를 위한 통홍삼 분말 농축액 및 통홍삼액 제조 방법 Download PDFInfo
- Publication number
- WO2017119565A1 WO2017119565A1 PCT/KR2016/007478 KR2016007478W WO2017119565A1 WO 2017119565 A1 WO2017119565 A1 WO 2017119565A1 KR 2016007478 W KR2016007478 W KR 2016007478W WO 2017119565 A1 WO2017119565 A1 WO 2017119565A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- red ginseng
- ginseng powder
- producing
- powder
- fermented
- Prior art date
Links
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 292
- 239000000843 powder Substances 0.000 title claims abstract description 136
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 37
- 238000000855 fermentation Methods 0.000 title claims abstract description 36
- 230000004151 fermentation Effects 0.000 title claims abstract description 36
- 239000007788 liquid Substances 0.000 title abstract description 12
- 239000004480 active ingredient Substances 0.000 title description 25
- 238000010521 absorption reaction Methods 0.000 title description 14
- 238000000354 decomposition reaction Methods 0.000 title 1
- 230000029087 digestion Effects 0.000 title 1
- 230000002255 enzymatic effect Effects 0.000 title 1
- 235000014483 powder concentrate Nutrition 0.000 title 1
- 239000006185 dispersion Substances 0.000 claims abstract description 71
- 108010047754 beta-Glucosidase Proteins 0.000 claims abstract description 34
- 102000006995 beta-Glucosidase Human genes 0.000 claims abstract description 34
- 230000001965 increasing effect Effects 0.000 claims abstract description 33
- 238000010298 pulverizing process Methods 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims description 108
- 239000002245 particle Substances 0.000 claims description 106
- 238000000227 grinding Methods 0.000 claims description 66
- 235000008434 ginseng Nutrition 0.000 claims description 35
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 34
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 33
- 239000011259 mixed solution Substances 0.000 claims description 24
- 241000228347 Monascus <ascomycete fungus> Species 0.000 claims description 23
- 238000010438 heat treatment Methods 0.000 claims description 20
- 230000001678 irradiating effect Effects 0.000 claims description 16
- 238000000926 separation method Methods 0.000 claims description 16
- 239000002904 solvent Substances 0.000 claims description 15
- 239000013535 sea water Substances 0.000 claims description 11
- 244000113306 Monascus purpureus Species 0.000 claims description 6
- 238000000265 homogenisation Methods 0.000 claims description 6
- 241000208340 Araliaceae Species 0.000 claims description 5
- 235000002322 Monascus purpureus Nutrition 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 241001052469 Monascus kaoliang Species 0.000 claims description 4
- 241001095209 Monascus sp. (in: Fungi) Species 0.000 claims description 4
- 229940057059 monascus purpureus Drugs 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 3
- 241000131482 Bifidobacterium sp. Species 0.000 claims description 3
- 241000959640 Fusobacterium sp. Species 0.000 claims description 3
- 241000186610 Lactobacillus sp. Species 0.000 claims description 3
- 241000611831 Prevotella sp. Species 0.000 claims description 3
- 230000001939 inductive effect Effects 0.000 claims description 3
- 241000186000 Bifidobacterium Species 0.000 claims description 2
- 241001267419 Eubacterium sp. Species 0.000 claims description 2
- 241000186660 Lactobacillus Species 0.000 claims description 2
- 229940039696 lactobacillus Drugs 0.000 claims description 2
- 238000003801 milling Methods 0.000 claims description 2
- 241000347881 Kadua laxiflora Species 0.000 claims 1
- 229930182494 ginsenoside Natural products 0.000 abstract description 16
- 229940089161 ginsenoside Drugs 0.000 abstract description 10
- 238000006243 chemical reaction Methods 0.000 abstract description 4
- 230000008569 process Effects 0.000 description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 35
- 244000131316 Panax pseudoginseng Species 0.000 description 31
- 229930182490 saponin Natural products 0.000 description 25
- 235000017709 saponins Nutrition 0.000 description 25
- 150000007949 saponins Chemical class 0.000 description 25
- 230000000052 comparative effect Effects 0.000 description 23
- 230000000694 effects Effects 0.000 description 16
- 239000000047 product Substances 0.000 description 15
- 102000004190 Enzymes Human genes 0.000 description 13
- 108090000790 Enzymes Proteins 0.000 description 13
- 229940088598 enzyme Drugs 0.000 description 13
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 13
- 239000002994 raw material Substances 0.000 description 11
- 230000002829 reductive effect Effects 0.000 description 10
- 230000008961 swelling Effects 0.000 description 10
- RWXIFXNRCLMQCD-JBVRGBGGSA-N (20S)-ginsenoside Rg3 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RWXIFXNRCLMQCD-JBVRGBGGSA-N 0.000 description 8
- PYXFVCFISTUSOO-HKUCOEKDSA-N (20S)-protopanaxadiol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@H]([C@@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C PYXFVCFISTUSOO-HKUCOEKDSA-N 0.000 description 8
- PYXFVCFISTUSOO-UHFFFAOYSA-N betulafolienetriol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC(C(C)(O)CCC=C(C)C)C4C(O)CC3C21C PYXFVCFISTUSOO-UHFFFAOYSA-N 0.000 description 8
- SWQINCWATANGKN-UHFFFAOYSA-N protopanaxadiol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3CCC21C SWQINCWATANGKN-UHFFFAOYSA-N 0.000 description 8
- 238000001704 evaporation Methods 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 239000001965 potato dextrose agar Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 230000008020 evaporation Effects 0.000 description 6
- 239000012467 final product Substances 0.000 description 6
- 230000001766 physiological effect Effects 0.000 description 6
- 239000002562 thickening agent Substances 0.000 description 6
- 238000010586 diagram Methods 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- SHCBCKBYTHZQGZ-DLHMIPLTSA-N protopanaxatriol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2[C@@H](O)C[C@@]3(C)[C@]4(C)CC[C@H]([C@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C SHCBCKBYTHZQGZ-DLHMIPLTSA-N 0.000 description 5
- BBEUDPAEKGPXDG-UHFFFAOYSA-N protopanaxatriol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC3C4(C)CCC(O)C(C)(C)C4C(O)CC23C BBEUDPAEKGPXDG-UHFFFAOYSA-N 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 241000589516 Pseudomonas Species 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000002612 dispersion medium Substances 0.000 description 4
- 238000006911 enzymatic reaction Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 238000001223 reverse osmosis Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 241000589774 Pseudomonas sp. Species 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 235000008504 concentrate Nutrition 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 230000005670 electromagnetic radiation Effects 0.000 description 3
- 239000010419 fine particle Substances 0.000 description 3
- 230000005484 gravity Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 2
- 108010051457 Acid Phosphatase Proteins 0.000 description 2
- 102000013563 Acid Phosphatase Human genes 0.000 description 2
- 241000228245 Aspergillus niger Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 241000030999 Monascus pilosus Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 238000000909 electrodialysis Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000005189 flocculation Methods 0.000 description 2
- 230000016615 flocculation Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- FVIZARNDLVOMSU-UHFFFAOYSA-N ginsenoside K Natural products C1CC(C2(CCC3C(C)(C)C(O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O FVIZARNDLVOMSU-UHFFFAOYSA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000008821 health effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 239000002352 surface water Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- RMZNXRYIFGTWPF-UHFFFAOYSA-N 2-nitrosoacetic acid Chemical compound OC(=O)CN=O RMZNXRYIFGTWPF-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 108091000069 Cystinyl Aminopeptidase Proteins 0.000 description 1
- 102000030900 Cystinyl aminopeptidase Human genes 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 241000186394 Eubacterium Species 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- AGBCLJAHARWNLA-DQUQINEDSA-N Ginsenoside RG2 Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@@](C)(O)CCC=C(C)C)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O AGBCLJAHARWNLA-DQUQINEDSA-N 0.000 description 1
- XIRZPICFRDZXPF-UHFFFAOYSA-N Ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CC(O)C3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O XIRZPICFRDZXPF-UHFFFAOYSA-N 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 235000007189 Oryza longistaminata Nutrition 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 241000168720 Panax japonicus Species 0.000 description 1
- 235000003174 Panax japonicus Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- OORMXZNMRWBSTK-LGFJJATJSA-N dammarane Chemical compound C1CCC(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@H]([C@H](C)CCCC(C)C)[C@H]4CC[C@@H]3[C@]21C OORMXZNMRWBSTK-LGFJJATJSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000012851 eutrophication Methods 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- -1 ginsenosides F1 Chemical class 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 150000004676 glycans Polymers 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/30—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/25—Removal of unwanted matter, e.g. deodorisation or detoxification using enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/40—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
- B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
- B02C19/00—Other disintegrating devices or methods
- B02C19/18—Use of auxiliary physical effects, e.g. ultrasonics, irradiation, for disintegrating
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
- B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
- B02C19/00—Other disintegrating devices or methods
- B02C19/18—Use of auxiliary physical effects, e.g. ultrasonics, irradiation, for disintegrating
- B02C19/186—Use of cold or heat for disintegrating
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
- B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
- B02C21/00—Disintegrating plant with or without drying of the material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
- B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
- B02C23/00—Auxiliary methods or auxiliary devices or accessories specially adapted for crushing or disintegrating not provided for in preceding groups or not specially adapted to apparatus covered by a single preceding group
- B02C23/08—Separating or sorting of material, associated with crushing or disintegrating
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
- B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
- B02C4/00—Crushing or disintegrating by roller mills
- B02C4/28—Details
- B02C4/30—Shape or construction of rollers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
- B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
- B02C4/00—Crushing or disintegrating by roller mills
- B02C4/28—Details
- B02C4/42—Driving mechanisms; Roller speed control
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/10—Drying, dehydrating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/26—Homogenisation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/31—Mechanical treatment
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/38—Multiple-step
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/48—Ultrasonic treatment
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01021—Beta-glucosidase (3.2.1.21)
Definitions
- the present invention relates to a method for preparing a fermented red ginseng powder dispersion with increased dispersibility and ginsenoside content.
- Ginseng is a perennial herbaceous herbaceous plant belonging to the Panax of the Araliaceae in terms of plant taxonomy and has long been used as an important herb in herbal medicine.
- Saponins of ginseng have physiological effects such as anticancer activity, antioxidant activity, arteriosclerosis and hypertension prevention, liver function improvement, antifatigue, antistress action, anti-aging, brain activity promotion, anti-inflammatory activity, allergic disease treatment and protein synthesis ability. It is known that Korean red ginseng has excellent physiological activities such as antioxidant, hypotension, alcoholic hyperlipidemia, hypoglycemic action.
- Ginseng is generally divided into white ginseng and red ginseng according to processing method.
- White ginseng refers to unprocessed ginseng mined from the field, that is, dried ginseng as it is.
- Red ginseng is steamed and dried and processed with saponin. Many chemical changes are involved, including amino acid changes.
- Red ginseng produces saponin components such as ginsenosides Rg2, Rg3, Rh1, and Rh2 which do not exist in ginseng due to the heat applied in the manufacturing process, and the active ingredients unique to red ginseng are cancer prevention, cancer cell growth inhibitory, It can be expected to have excellent pharmacological effects due to excellent neuroprotective and learning ability, antithrombotic action and antioxidant action.
- red ginseng The most representative product of the red ginseng product is red ginseng as a raw material and extracted with water or other solvents.
- the active ingredient of red ginseng is dissolved in the extract product and processed into an easily eatable form.
- some active ingredients remain in the red ginseng, so that a large amount of useful human components including ginsenosides are ingested and discarded.
- the liquid red ginseng extract product containing the active ingredient of red ginseng is usually prepared by mixing red ginseng concentrate and other raw materials in purified water, or by preparing a red ginseng extract to directly produce it.
- red ginseng product has a low ginsenoside content, or the red ginseng can not preserve the flavor of the red ginseng as it is, the functional and product properties were insufficient.
- red ginseng powder dispersion is suspended in the liquid by grinding the whole red ginseng in a fine size, the red ginseng particles can be ingested as a whole because it is not only excellent effect, but also easy to eat, there is an excellent productability.
- the red ginseng particles are suspended in the liquid, and as time passes, the particles may be precipitated or aggregated, thereby lowering the texture or taste.
- cohesion is rather increased.
- red ginseng powder dispersion was limited due to the negative perception of the consumer due to the negative recognition of the consumer, or the dispersion of the red ginseng particles effectively.
- Various attempts have been made to improve functionality along with product dispersion.
- ginsenosides such as Rb1, Rb2, Rc, Rd, and Re
- Rb1, Rb2, Rc, Rd, and Re are not directly absorbed by the human body even though they are contained in large amounts in red ginseng or ginseng. It can be degraded and converted to minor saponins (secondary metabolites) such as ginsenosides F1, F2, Rg3, compound-K, etc., and then absorbed and expressed in efficacy.
- minor saponins secondary metabolites
- red ginseng possesses excellent pharmacological activity
- actual red ginseng may have different medicinal effects due to differences in the distribution and activation of individual intestinal microorganisms.
- the present invention has been made to solve the above-described problems, to provide a method for producing a red ginseng powder dispersion with improved dispersibility of the red ginseng particles.
- the present invention is to provide a method for preparing a red ginseng powder dispersion with increased body absorption of useful components contained in red ginseng.
- the particle size of the powder in the step (a) may be 2 to 20 micrometers ( ⁇ m).
- the grinding in step (a) may be carried out at -20 to -5 °C.
- the particle size of the powder in the step (a) may be 2 to 20 micrometers ( ⁇ m).
- the step (b) may be performed for 1 to 5 hours at a pressure of 1.5 to 4 bar (bar).
- the step (b) may be carried out at 30 to 45 °C.
- the mixed solution in step (b) may comprise a red ginseng extract.
- the red ginseng extract may be prepared using a desalted deep sea water as a solvent.
- the fermentation strain in the step (c) is Monascus sp . , Lactobacillus sp . , Bifidobacterium sp . , Prevotella sp . sp . ), Fusobacterium sp . , And Eubacterium genus sp . ) May be selected from the group consisting of one or more strains.
- the Pseudomonas is Pseudomonas sp coarse coarse aengka (Monascus anka), Pseudomonas coarse fur pure mouse (Monascus purpureus ), Monascus pilosus , Monascus louver ruber ), and Monascus kaoliang .
- step (c) may be carried out at 25 to 35 °C for 3 to 15 days.
- the method may further include heat treating the red ginseng before the step (a).
- the heat treatment may supply moisture to the red ginseng surface and irradiate far infrared rays.
- the heat treatment may be performed for 1 to 4 hours.
- the step (e) may be performed three or more times at a pressure of 200 to 800 bar (bar).
- the step (f) may be performed under a vacuum of 1 to 20kPa pressure.
- beta glucosidase beta glucosidase
- step (a) may be performed by a low speed rotation of 100 to 500rpm.
- the wavelength of the far infrared ray in the step (b) may be 20 to 40 ⁇ m.
- step (c) in the step (c) it can form a swirl flow and induce the collision between the red ginseng particles can be pulverized.
- the ultrasonic wave in step (c) may increase the frequency of collision between particles.
- the frequency of the ultrasonic wave in step (c) may be 15KHz to 20KHz, amplitude may be 5 to 50 ⁇ m.
- the step (c) may be performed at -20 to -5 °C.
- the first grinding portion including one or more helical roller rotating in contact with; A heat treatment unit irradiating far infrared rays to the red ginseng; A second grinding part which forms swirl flow and induces collision between the red ginseng particles to pulverize the red ginseng; And a separator for collecting red ginseng particles discharged from the second grinding unit.
- the helical roller may rotate at a speed of 100 to 500rpm.
- the heat treatment unit may irradiate far infrared rays having a wavelength of 20 to 40 ⁇ m.
- the second grinding unit may increase the frequency of collision between red ginseng particles by irradiating the ultrasonic wave.
- the frequency of the ultrasonic waves may be 15KHz to 20KHz, amplitude may be 5 to 50 ⁇ m.
- the second grinding unit may include one or more cooling devices for supplying low temperature air.
- the low temperature air may be -20 to -5 °C.
- the separation unit may include a vacuum pump for reducing the pressure inside.
- the red ginseng powder dispersion prepared according to the present invention may be stably dispersed in the liquid by increasing the hydrophilicity of the surface of the red ginseng particles by fermentation and minimizing interaggregation and precipitation over time.
- the red ginseng powder dispersion prepared according to the present invention has a high content of ginsenoside in a form that is easily absorbed by the body by fermentation, so as to satisfy consumer's preference as a high-quality product, as well as excellent functionality and taste. .
- FIG. 1 is a diagram illustrating a method for preparing a fermented red ginseng powder dispersion according to an embodiment of the present invention.
- FIG. 2 is a schematic diagram illustrating a method for preparing a fermented red ginseng powder dispersion according to an embodiment of the present invention.
- Figure 3 is a schematic of the manufacturing method of the nano red ginseng powder according to an embodiment of the present invention.
- Figure 4 is a schematic diagram of the manufacturing apparatus of the nano red ginseng powder according to an embodiment of the present invention.
- the numerical range includes the numerical values defined in the range. All maximum numerical limits given throughout this specification include all lower numerical limits as if the lower numerical limits were clearly written. All minimum numerical limits given throughout this specification include all higher numerical limitations as if the higher numerical limit were clearly written. All numerical limitations given throughout this specification will include all better numerical ranges within the broader numerical range, as the narrower numerical limitations are clearly written.
- FIG. 1 and 2 is a diagram illustrating a method for preparing a fermented red ginseng powder dispersion according to an embodiment of the present invention.
- the method for preparing a fermented red ginseng powder dispersion comprises the steps of (a) grinding red ginseng to obtain a powder; (b) adding the powder to a mixed solution containing beta glucosidase and reacting it; (c) inoculating and fermenting the fermentation strain in the mixed solution; And (d) may comprise the step of adjusting the concentration of the mixed solution to a predetermined range.
- red ginseng refers to red ginseng dried by steaming ginseng, and the origin, type and form of ginseng are not limited.
- ginseng Panax ginseng CA. Meyer
- hwagisam Panax quinquefolium
- jeonchilsam Panax notoginseng
- jukjeol three Panax japonicum
- Panax ginseng trifolium or Himalayan ginseng ( Panax pseudoginseng )
- Himalayan ginseng Panax pseudoginseng
- the ginseng is sufficient if the ginseng generally used in the production of red ginseng, the type is not particularly limited.
- the ginseng may be used such as ginseng, white ginseng, camphor ginseng, and the like is not limited.
- the ginseng may use any part of the ginseng.
- the ginseng may be main ginseng or misam, or may be used together with the main ginseng and misam.
- the red ginseng raw material in the method of preparing the powder dispersion may be directly used as raw material ginseng unprocessed in consideration of the quality of the final product or market demand as well as red ginseng prepared by steaming ginseng.
- the grinding may be carried out at -20 to -5 °C, the particle size of the powder may be 2 to 20 micrometers ( ⁇ m).
- the pulverization is performed at a low temperature, it is possible to suppress the destruction of useful components of the human body by frictional heat, and to refine the powder to increase the water solubility index (WSI).
- the red ginseng particles are pulverized at a low temperature, thereby minimizing the intergranular phenomenon occurring in the ultrafine grinding process.
- the powder is ultra-fine, the water absorption capacity (WAI), swelling (Swelling powder, SW) is reduced while the water solubility is increased, so the ability to bind with water increases and the coagulation or precipitation between fine particles It can be dispersed uniformly in water.
- the ultra fine powder has a large specific surface area representing a surface area per unit weight, and the large specific surface area can increase the contact area between the solid and the solvent, thereby increasing the solubility of the material having low solubility in the body fluid. . Therefore, the ultra fine powder may be dissolved in the human body in a shorter time than the coarsely pulverized powder of the same weight, thereby increasing the absorbency of the red ginseng component to improve the bioavailability of the red ginseng component.
- the powder in step (b) may be added to the mixed solution containing beta glucosidase ( ⁇ -Glucosidase) and reacted.
- the red ginseng is reacted with the ginsenoside-converting enzyme-containing mixed solution for a predetermined time before the microorganism fermentation step to allow the enzyme to be absorbed inside the red ginseng.
- the "beta-glucosidase” is one of cellulase, an enzyme that breaks down cellulose, and converts cellobiose, a glucose dimer, to glucose, and insoluble fibrin. Can be effectively decomposed.
- the beta glucosidase may be derived from Aspergillus niger, but is not particularly limited as long as it has equivalent conversion activity.
- the beta glucosidase has excellent saponin resolution, and may convert major saponins such as Rb1, Rb2, Rc, Rd, and Re into minor metabolites. That is, the beta glucosidase may convert major saponins of PPD (protopanaxadiol) type or PPT (protopanaxatriol) type into soluble minor saponins.
- the "protopanaxadiol (PPD) type saponin” is a dammarane-based saponin, which refers to a ginsenoside having two numbers of hydroxyl groups (-OH) attached to a non-glycone, for example, Rb1 and Rb2. , Rc, Rd, Re, Rf or Rg1.
- the saponin of the PPD type may include all saponins that can be converted to ginsenoside Rg3 by the activity of the ginsenoside glycosidase.
- the soluble "minor saponin” is a relatively easy to absorb in the minor (minor) form, which is generated by the hydrolysis of glucose of the 20th carbon of the PPD type or PPT type saponin which is not easily absorbed in the body Mean saponin, but the kind is not particularly limited
- the minor saponin may include ginsenosides Rd, Rg3, Rg2, Rh1, Rh2, F1, CO, or C-Mc1, preferably Rd, It may be Rg3, Rg2 or Rh1.
- the beta glucosidase enzyme may promote the conversion of major saponin components inside the red ginseng and increase the proportion of hydrophilic groups on the particle surface in the subsequent fermentation step, thereby increasing the absorption rate of useful components and the dispersibility of the ground red ginseng particles.
- the intestinal beta glucosidase enzyme does not exert sufficient activity to convert saponin in red ginseng into useful ingredients due to its acidic properties, so it is possible to improve the functionality of the product by performing enzyme treatment in advance in the red ginseng product processing step. have.
- the step (b) may be performed for 1 to 5 hours at a pressure of 1.5 to 4 bar (bar). Since the mixed solution containing the beta glucosidase can be effectively introduced into the red ginseng at a high pressure, it is possible to improve the reaction efficiency by increasing the pressure than usual conditions. If the pressure is less than 1.5 bar, the absorption efficiency may not increase sufficiently. If the pressure is higher than 4 bar, the rate of absorption increase due to the pressure increase may not be proportional to the process cost. In addition, if the reaction time is less than 1 hour, the enzyme may not be sufficiently absorbed into the red ginseng, and if more than 5 hours, the absorption efficiency is lowered, which may be inefficient in terms of cost and time.
- step (b) may be carried out at 30 to 45 °C. If it is less than 30 °C red tissue of the ginseng particles and the internal pores are reduced because the introduction efficiency of the enzyme may be lowered, if it is above 45 °C the active ingredient susceptible to heat may be modified or the activity of the enzyme is reduced.
- the enzyme may be stirred so that it can be effectively introduced into the red ginseng particles, preferably at 10 to 15rpm.
- the agitation may be typically performed by a mechanical device such as an impeller installed at the center of the chamber and rotated by a motor, but may be freely deformed in consideration of characteristics of the process system. However, if the stirring speed is excessively slow or fast, the desired purpose may not be achieved, or the active ingredient may be deformed or lost, so that the stirring speed may be appropriately controlled within the above range.
- the mixed solution in the step (b) may further comprise a red ginseng extract.
- extract refers to a solvent in which the active ingredient contained in the extract raw material is transferred by contacting the solvent and the extract raw material under specific conditions, and the red ginseng extract may include an active ingredient contained in the fermented red ginseng.
- the fermented red ginseng powder dispersion may be a mixed solution in which fine red ginseng particles are dispersed in purified water, but when the purified water is replaced with red ginseng extract, dispersibility and productability may be further improved.
- the red ginseng extract has various active ingredients contained in the red ginseng by the extraction process, so the polarity is relatively high, so that the hydrophilic interaction with the refined red ginseng particles can be improved, and thus contains a large amount of functional ingredients useful for the human body. Excellent health improvement effects can be realized.
- the kind of the solvent used in the extraction process is not particularly limited, and the kind of the solvent may be changed in consideration of the process conditions.
- the red ginseng extract is washed with water, dried with red ginseng, dried and pulverized, and extracted with conventional methods such as reflux circulation extraction, pressure extraction, and ultrasonic extraction for a predetermined time with a solvent amounting to 8 to 12 times the weight of the raw material. It can be prepared by filtration.
- the extract may be obtained in a powder state by an additional process such as distillation under reduced pressure or freeze drying.
- the red ginseng extract may be prepared using a desalted deep sea water as a solvent.
- the deep sea water means seawater circulating in a deep sea of 200 m or less, which is clearly distinguished from surface waters affected by precipitation, wind volume, and evaporation near sea level.
- the seawater does not stay in one place and constantly circulates, and when the circulating seawater reaches the glacier region, the gravity increases, causing the gravity to gradually go down to below 200m, and the seawater that has cooled down does not mix with the surface water due to the difference in density. It can form huge layers with boundaries.
- the deep sea water is stabilized at low temperature and contains almost no organic matter or pathogens, and has excellent resource characteristics such as safety, cleanliness and eutrophication, which are rich in nutrients essential for the growth of marine plants.
- One red ginseng extract contains abundant minerals along with the active ingredients contained in red ginseng, which is not only excellent in improving health, but also significantly increases the dispersion stability of red ginseng particles.
- the desalted deep sea water may be obtained by applying any technique known in the art, and may be used, but not limited to, flash evaporation, sea water freezing, reverse osmosis, ion exchange resin, electrodialysis, and the like. It may be appropriately selected in consideration of its characteristics.
- the reverse osmosis method is a method of removing the salt using a reverse osmosis membrane
- the electrodialysis method refers to a method of selectively lowering the concentration of sodium without changing the concentration of the mineral required.
- step (c) the fermentation strain may be inoculated and fermented into the mixed solution, and the fermentation may be performed at 25 to 35 ° C. for 3 to 15 days.
- the fermentation strain may convert major saponins with low absorption rate into human soluble minor saponins through ginsenoside metabolism.
- the fermentation strain is Monascus sp . ), Lactobacillus genus (Lactobacillus sp.), In bacteria, bifidobacteria (Bifidobacterium sp . , Prevotella sp . ), Fusobacterium sp . ), And Eubacterium sp . May be selected from the group consisting of one or more strains, preferably Monascus strain may be selected.
- the strain of the genus Monascus belongs to Ascomycetes, a fungus that produces red pigment using starch, and inoculated and incubated the strain of the monascus into rice, called red rice koji (red yeast). It's Cozy.
- the strain of the genus Monascus has been widely used for the production of red wine or other fermented foods for a long time, and there have been many reports on the treatment and medical efficacy of diseases.
- the strain may impart hydrophilicity to the surface of the particles in the process of converting the organic material of the red ginseng particles, and the fermented red ginseng particles may increase the hydrophilicity, thereby forming a stable colloidal state. That is, since the hydrophilic colloid can be easily dispersed in water, the fermented red ginseng powder dispersion according to the present invention can not only have excellent dispersibility without a separate chemical additive such as an emulsifier, but also saponin in the form of easy ingestion by fermentation. As the content increases, the health promoting effect can also be improved.
- the Pseudomonas is Pseudomonas sp coarse coarse aengka (Monascus anka), Pseudomonas coarse fur pure mouse (Monascus purpureus ), Monascus pilosus , Monascus louver ruber ), and Monascus kaoliang .
- the strain of the genus Monascus (esterase), leucine arylamidase (leucine arylamidase), valine arylamidase (valine arylamidase), cystine arylamidase (acid phosphatase), acid phosphatase, Have at least one activity selected from the group consisting of naphtol-AS-phosphohydrolase, alpha-glucosidase and beta-glucosidase
- major saponins of the PPD (protopanaxadiol) type or PPT (protopanaxatriol) type contained in red ginseng may be converted into soluble minor saponins.
- the mixed solution containing the beta glucosidase ( ⁇ -Glucosidase) in the step (b) was converted into a form that is easy for fermentation by reacting with red ginseng, the fermentation efficiency by the strain of the genus Monascus in the step (c) This can be further improved.
- the beta glucosidase may soften the hard fiber of red ginseng and convert dimers that the strain of Monascus is not easily ingested into monomers, thereby significantly increasing the culture efficiency of the strain of Monascus.
- the method may further include heat treating the red ginseng before the step (a), and the heat treatment may be performed for 1 to 4 hours.
- the mixed solution may be easily absorbed by heat-treating the red ginseng before the process.
- the red ginseng may increase the porosity of the red ginseng by heat treatment and the fiber structure becomes flexible, so that the absorption rate of the mixed solution may be increased, and at the same time, the efficiency of the subsequent fermentation process may be improved by the heat treatment process.
- the heat treatment may supply moisture to the surface of the red ginseng and irradiate far infrared rays.
- the far-infrared ray is an electromagnetic radiation of a long wavelength in the infrared radiation with a wavelength of 50 to 1,000 ⁇ m, long wavelength can be easily absorbed into the red ginseng, it is possible to heat the red ginseng as a whole.
- the far infrared rays increase the physiological activity of the red ginseng, and activate the tissue is suitable for the production of high-quality red ginseng products.
- the concentration of the mixed solution may be adjusted to a predetermined range.
- the fermented red ginseng powder dispersion may vary in concentration and viscosity according to the price of the final product and the demand of the consumer, and may appropriately control the content of the ground red ginseng particles and water.
- thickeners may be added.
- the red ginseng powder dispersion has excellent dispersibility due to the increased solubility of the powder particles by the enzyme and the fermentation strain, but it is possible to optimize the quality and characteristics of the final product by adding a small amount of thickener according to cost or process conditions. have.
- the thickener may be a suspending agent, a sedimentation inhibitor, a gel forming agent, or a swelling agent, but the type thereof is not particularly limited.
- the homogenization may mean a treatment by an emulsifier such as a pressure type, an ultrasonic type, or a stirring type, and preferably, an ultrasonic emulsifier or an ultra high pressure homogenizer may be used.
- an emulsifier such as a pressure type, an ultrasonic type, or a stirring type
- an ultrasonic emulsifier or an ultra high pressure homogenizer may be used.
- the ultrasonic emulsifier can improve the transparency of the powder dispersion, and the ultra-high pressure homogenizer can shorten the time required for the process because of the excellent homogenization efficiency.
- the homogenized dispersion may be concentrated at low temperature under a vacuum of 40 ° C. or less, and preferably under a vacuum of 1 to 20 kPa.
- the concentration refers to an operation of increasing the concentration of solids by removing moisture
- the concentration method is not particularly limited. That is, evaporation concentration to evaporate moisture, freeze concentration to freeze the solvent and mechanically separate the produced ice, reverse osmosis concentration to separate the water through the semi-permeable membrane by applying pressure above the osmotic pressure of the concentrate, but preferably The evaporation concentration method can be used.
- the active ingredient contained in the red ginseng extract may be deformed or destroyed at a high temperature, it is preferable to control the temperature at an appropriate level in the process, and to apply a vacuum concentration method of concentrating by evaporating the solvent under reduced pressure. Can be.
- the red ginseng powder dispersion is concentrated in a vacuum to increase the concentration of the dispersion, that is, the specific gravity of the red ginseng particles relative to the dispersion medium at a relatively low temperature, but when the temperature is set too low, evaporation of the solvent It does not occur smoothly and may reduce the efficiency of the entire process.
- the pressure is less than 1 kPa, the process cost may be excessively exceeded, and if the pressure exceeds 20 kPa, the evaporation efficiency may be reduced, so that the pressure and temperature may be appropriately controlled in consideration of product quality and process conditions.
- the red ginseng powder dispersion is preferably in the content of the red ginseng particles more than 70% by weight relative to the total dispersion weight in consideration of the functionality and product properties of the final product, the concentration may be changed in consideration of the quality of the final product or the market demand.
- the red ginseng powder may be implemented in the form of a red ginseng concentrate, which is in high demand in the market through the concentration process, and the red ginseng powder may be stably dispersed in a dispersion medium since the concentration process is performed after the homogenization process.
- a thickener may be added to control the concentration or viscosity of the red ginseng powder dispersion.
- the red ginseng powder dispersion has excellent dispersibility due to the increased solubility of the powder particles by the enzyme and the fermentation strain, but it is possible to optimize the quality and characteristics of the final product by adding a small amount of thickener according to cost or process conditions. have.
- the thickener may be a suspending agent, a sedimentation inhibitor, a gel forming agent, or a swelling agent, but the type thereof is not particularly limited.
- Figure 3 is a schematic of the manufacturing method of the nano red ginseng powder according to an embodiment of the present invention.
- the manufacturing method of the red ginseng powder may increase the water solubility index (WSI) by nanoparticles of red ginseng, and may impart hydrophilicity to the surface of the red ginseng particles through a fermentation process. Therefore, the red ginseng powder prepared by the above method can be uniformly dispersed in the dispersion medium and the aggregation between the particles can be minimized.
- WSI water solubility index
- the method for producing the nano red ginseng powder may include sequentially grinding the red ginseng, irradiating far infrared rays, and grinding the red ginseng.
- the red ginseng may be coarsely ground to a particle size of 90 to 150 micrometers ( ⁇ m), and the first coarsely ground red ginseng powder may be easily milled.
- the coarse pulverization refers to a process of crushing a raw material introduced through a crushing means such as a roller or a milling cutter to a predetermined size.
- the shredding means may be a spiral roller, a ball mill, a rod mill, a roller mill, a wheeler mill, a hammer mill, a tumbling mill, Or a pin mill, but is not limited thereto.
- step (a) may be performed by a low speed rotation of 100 to 500rpm.
- the coarsely pulverization is performed at a low rotational speed, deformation of the active ingredient due to excessive frictional heat can be suppressed, and contamination or raw material loss due to dust generation can be minimized.
- the rotational speed is less than 100rpm, the process efficiency may be reduced and the production cost and time may be excessively consumed. If the rotational speed is more than 500rpm, the active ingredient of red ginseng may be lost by frictional heat.
- step (b) after the coarse grinding can be irradiated with far infrared rays on the surface of the red ginseng.
- the far-infrared ray is an electromagnetic radiation of a long wavelength in the infrared radiation with a wavelength of 50 to 1,000 ⁇ m, increase the physiological activity of red ginseng and activate the tissue, thereby improving the health improvement effect of red ginseng powder.
- the wavelength of the far-infrared ray is not particularly limited, but an optimal switching capability may be realized in the range of 20 to 40 ⁇ m.
- natural antioxidants include polymers such as polyphenols, tocopherols, flavonoids, and the like, which are polymers, and the far-infrared rays may liberate the polymers with low molecules, thereby increasing the antioxidant capacity of red ginseng. can do.
- the red ginseng may be finely ground to a particle size of 2 to 20 micrometers ( ⁇ m).
- the red ginseng is ultra-fine, so that the water absorption capacity (WAI), swelling powder (SW) is reduced while the water solubility is increased, so the ability to bind with water increases and does not form the flocculation or precipitation between fine particles. It can be uniformly dispersed in water.
- the ultra fine powder has a large specific surface area representing a surface area per unit weight, and the large specific surface area can increase the contact area between the solid and the solvent, thereby increasing the solubility of the material having low solubility in the body fluid. .
- the ultra fine powder may be dissolved in the human body in a shorter time than the coarsely pulverized powder of the same weight, thereby increasing the absorbency of the red ginseng component to improve the bioavailability of the red ginseng component.
- the coarsely pulverized red ginseng particles may be introduced together with a high-speed fluid to form a swirl flow, and may cause the mutual collision between the particles in the swirl flow to pulverize the red ginseng particles.
- the method for forming the swirl flow may be a method commonly used in the art, for example, by blowing a compressed air or water vapor of more than a few atmospheric pressure from a specific nozzle to form a swirl flow and accelerate the suction by grinding the raw material Then, a method of pulverizing the particles circulating in the air stream may be applied by causing an interparticle collision or a collision between the particle and the collision plate.
- the ultrasonic wave in the step (c) it can increase the frequency of collision between particles. Since the collision between the particles is generated by the swirl flow may be pulverized, it can further increase the grinding efficiency by irradiating ultrasonic waves.
- the range of the ultrasonic wave is not particularly limited, but preferably, the frequency may be 15 KHz to 20 KHz, and the amplitude may be 5 to 50 ⁇ m. Within this range, the ultrasonic wave may impart an effective vibration to the circulating red ginseng particles and increase the number of collisions and the collision strength between particles to improve the fine grinding effect.
- the pulverization may be carried out at -20 to -5 °C.
- red ginseng particles are circulated in the swirling flow, so that the red ginseng particles are continuously cooled in the grinding process to generate less heat, but can be completely blocked from deformation or loss of the active ingredient in red ginseng by fine grinding at cryogenic temperatures.
- the pulverization process is carried out under cryogenic conditions, the red ginseng particles are frozen and the hardness becomes stronger, so that the grinding efficiency due to the collision can be significantly increased.
- Fermented red ginseng powder dispersion prepared by the above method may be completed by filling the packaging material after the selective sterilization process.
- the sterilization process may be performed through a sterilization method commonly used in the art, and if the sterilization temperature is excessively high, the ginsenoside component of the red ginseng particles may be destroyed or deformed, so that the sterilization may be performed at a temperature of 80 ° C. or lower. Can be.
- the first grinding portion 101 including one or more helical roller rotating in contact with; A heat treatment unit 102 for irradiating far infrared rays to the red ginseng; A second grinding unit 103 for forming a swirl flow and inducing collision between the red ginseng particles to pulverize the red ginseng; And a separator 104 for collecting the red ginseng particles discharged from the second grinding part 103.
- FIG 4 is a schematic diagram of the manufacturing apparatus of the nano red ginseng powder according to an embodiment of the present invention.
- the nano red ginseng powder manufacturing apparatus can combine the coarse grinding process and the fine grinding process to effectively nanoparticles without destroying the active ingredient of the red ginseng.
- the apparatus for manufacturing nano red ginseng powder may include a first grinding unit 101, a heat treatment unit 102, a second grinding unit 103, and a separation unit 104. It may be pulverized through each of the sequentially connected components of the manufacturing apparatus.
- the first grinding unit 101 may roughly grind red ginseng.
- the coarse grinding grinds red ginseng to a particle size of 90 to 150 micrometers to facilitate pre-processing prior to fine grinding and enables subsequent fine grinding processes.
- the first crushing unit 101 may include crushing means such as a spiral roller for coarsely crushing red ginseng, and may crush the red ginseng or ginseng in a predetermined size.
- the first grinding unit 101 is a spiral roller, a ball mill, a rod mill, a roller mill, a wheeler mill, a hammer mill, a tumbling
- the red ginseng may be ground through a mill or a pin mill, but the present invention is not limited thereto, and the grinding method is not limited as long as it can be coarsely ground so as to be pre-processed before grinding.
- the first grinding unit 101 may include one or more pairs of rollers, and the rollers may be crushed at least two times by gradually reducing the intervals to other intervals by adjusting the intervals. That is, two pairs of rollers at different intervals may be disposed adjacent to each other and then preliminarily crushed, and then secondarily compacted.
- the spiral roller may rotate at a speed of 100 to 500rpm.
- the active ingredient in the red ginseng may be destroyed by frictional heat and external force. Therefore, since the first grinding unit 101 performs coarse grinding at a low speed, it is possible to minimize deformation of the active ingredient due to excessive frictional heat, and to suppress contamination or loss of raw materials due to dust generation.
- the rotational speed is less than 100rpm, the process efficiency may be reduced and the production cost and time may be excessively consumed. If the rotational speed is more than 500rpm, the active ingredient of red ginseng may be lost by frictional heat.
- the heat treatment unit 102 may increase the physiological activity effect of the red ginseng by irradiating the far-infrared rays to the coarsely crushed red ginseng, preferably irradiated far infrared rays having a wavelength of 20 to 40 ⁇ m.
- the heat treatment unit 102 is connected to the first grinding unit 101, the coarse ground red ginseng may be transferred by a conveying means such as a conveyor belt.
- the coarsely pulverized red ginseng may be transferred to the heat treatment unit 102 and stayed for a predetermined time, and may be heat treated by far infrared rays, but the method is not limited thereto.
- the red ginseng may be heat treated while being transferred by the transfer means. .
- the heat treatment unit 102 may have one or more far-infrared lamps emitting far-infrared rays, and the far-infrared lamps may be changed at predetermined intervals by a transmission device to evenly emit far-infrared rays.
- the far-infrared ray is an electromagnetic radiation of a long wavelength in the infrared radiation with a wavelength of 50 to 1,000 ⁇ m, increase the physiological activity of red ginseng and activate the tissue, thereby improving the health improvement effect of red ginseng powder.
- the wavelength of the far-infrared ray is not particularly limited, but an optimal switching capability may be realized in the range of 20 to 40 ⁇ m.
- the second grinding unit 103 may form a swirl flow and induce the collision between the red ginseng particles to finely grind the red ginseng.
- the red ginseng is ultra-fine, so that the water absorption capacity (WAI), swelling powder (SW) is reduced while the water solubility is increased, so the ability to bind with water increases and does not form the flocculation or precipitation between fine particles. It can be uniformly dispersed in water.
- the ultra fine powder has a large specific surface area representing a surface area per unit weight, and the large specific surface area can increase the contact area between the solid and the solvent, thereby increasing the solubility of the material having low solubility in the body fluid. .
- the second grinding unit 103 may form the swirl flow by introducing the coarsely pulverized red ginseng particles together with a high-speed fluid, and may cause the mutual collision between the particles in the swirl flow to pulverize the red ginseng particles.
- the method of forming the swirl flow may be a method commonly used in the art, for example, by blowing compressed air or water vapor above a certain pressure from a specific nozzle to form a swirl flow, interparticle collisions or particles and It can cause the collision between the impingement plates, thereby pulverizing the particles circulating in the air stream.
- the second grinding unit 103 is a structure capable of forming a swirl flow in a commonly known chamber, and may include a cylindrical chamber and an injection nozzle capable of injecting high-pressure gas, and the red ginseng particles injected together with the fluid. Rotates in accordance with the flow of the fluid in the cylindrical chamber and the finely ground red ginseng particles may be discharged to the separation unit 104 by centrifugal force. At this time, an inert gas such as helium may be injected to form the swirl flow, or air may be used without fear of oxidation, but the type thereof is not particularly limited.
- the apparatus for forming the swirl flow may be used irrespective of the kind or structure thereof, and preferably the swirl flow may be formed at a rotation speed of 3,000 to 5,000 rpm.
- the pulverization by the swirl flow may be carried out under conditions that result in a volume average diameter reduction of at least 20% and a number average diameter reduction of at most 80%.
- the second grinding unit 103 may increase the frequency of collision between red ginseng particles by irradiating the ultrasonic wave. That is, the second grinding unit 103 may form a swirl flow and cause particle collision, thereby grinding the red ginseng particles, but when the ultrasonic wave is irradiated during the grinding process, the collision frequency between the particles increases and collides. Since the strength is strong, the grinding efficiency can be increased.
- the frequency of the ultrasonic wave may be 15KHz to 20KHz, amplitude may be 5 to 50 ⁇ m.
- the ultrasonic wave may impart an effective vibration to the circulating red ginseng particles and increase the number of collisions and the collision strength between particles to improve the fine grinding effect.
- the second grinding unit 103 may include one or more cooling devices for supplying low temperature air, and the low temperature air may be -20 to -5 ° C. Since the pulverization process is performed at cryogenic temperature, deformation or loss of the active ingredient in red ginseng may be blocked by heat, and since it is performed under cryogenic conditions, the hardness of the red ginseng particles may be increased, thereby significantly increasing the grinding efficiency due to collision.
- the second grinding unit 103 may include a heat exchange core for cooling the air in the atmosphere and a nozzle for injecting the cooled low temperature air therein, and used in the art. Various cooling methods can be applied.
- the separation unit 104 may collect the red ginseng particles discharged from the second grinding unit 103.
- the separation unit 104 is connected to one side of the second grinding unit 103 and may selectively separate the red ginseng particles refined in the second grinding unit 103.
- the red crushed red ginseng particles and the red ginseng particles which have not been sufficiently pulverized may be mixed, and the separation unit connected to the second grinding unit 103. 104 may classify only the red ginseng particles ground to a predetermined particle size and discharged to the outside.
- the classification means an operation of separating materials having different sizes or properties from each other, and the separating unit 104 may pass red ginseng particles having a predetermined particle size or less from a powder having particles of various particle sizes mixed therewith.
- the separation unit 104 by using a centrifugal force generated from a plurality of blades installed in the centrifugal rotor to block the large powder of more than a certain particle size introduced into the separation unit 104, Only powder particles can be selectively passed through.
- the separation unit 104 may form a low-pressure atmosphere to increase the separation efficiency of the finely divided red ginseng particles, the inside of the separation unit 104 so that the finely divided red ginseng particles can be effectively classified according to the particle size It may include a vacuum pump for reducing the pressure of.
- the low pressure atmosphere by the vacuum pump may form an upward airflow, and the red ginseng particles circulating in the upward airflow may be classified more precisely by the pressure action of the vacuum pump.
- Monascus mycelium ( M. purpureus , MP) used for the solid culture was distributed from the National Institute of Agricultural Science, Agricultural Genetic Resources Center (Suwon, Korea). The mycelium was incubated for 10 days at 25 ° C. in potato dextrose agar (PDA, Difco, Sparks, MD, USA) plate medium and inoculated in an erlenmeyer flask containing potato dextrose broth (PDB, Difco) and shake incubator (Jeio tech, Daejeon). , Korea) was subcultured every five days. The monascus mycelium was used for three times passage in PDB medium.
- PDA potato dextrose agar
- PDB erlenmeyer flask containing potato dextrose broth
- shake incubator Jeio tech, Daejeon
- Aspergillus niger strains obtained from the RDA Agricultural Genetic Resource Center were incubated at 30 ° C. in PDB (Potato Dextrose Broth) liquid medium for 3 days.
- the culture solution was centrifuged at 7,000 rpm for 10 minutes to separate the supernatant and the precipitate, and the supernatant was removed.
- the precipitate was suspended with 0.1 M potassium phosphate uffer, and the suspension was sonicated.
- the lysate was centrifuged at a speed of 12,000 rpm for 5 minutes to separate the supernatant and sediment, and the supernatant containing enzyme was taken.
- the prepared red ginseng was pulverized to a particle size of 10 ⁇ m using a low-temperature pulverizer was finely powdered.
- Monascus mycelium obtained in Preparation Example 1 was inoculated to the red ginseng powder separated after the above process, and fermented at 30 ° C. for 3 days. After completion of the fermentation process, a part of purified water was mixed to facilitate eating and homogenization three times at a pressure of 300 bar and a rotational speed of 10,000 rpm with a Homogenizer (HF-93, SMT company, Japan).
- a Homogenizer HF-93, SMT company, Japan
- the finished fermented red ginseng powder dispersion was sterilized at 70 ° C to complete the final sample.
- Red ginseng powder dispersion was prepared in the same manner as in Example 1 except that the infrared rays were irradiated for 2 hours and heat-treated before grinding the red ginseng using a low-temperature grinding machine.
- a red ginseng powder dispersion was prepared in the same manner as in Example 1, but instead of 50 ml of the mixed solution containing the beta-glucosidase enzyme of Preparation Example 2, 20 ml of the mixed solution containing the beta-glucosidase enzyme of Preparation Example 2 was prepared by hot water extraction. 30 ml of the red ginseng extract was mixed and used.
- a red ginseng powder dispersion was prepared in the same manner as in Example 1, except that red ginseng was coarsely ground to a particle size of 120 ⁇ m without fine grinding to a particle size of 10 ⁇ m to prepare a powder dispersion.
- Red ginseng powder dispersion was prepared in the same manner as in Example 1, but xanthan gum was added without fermentation using the Monascus mycelium to improve dispersion stability of the fine molecules.
- a red ginseng powder dispersion was prepared in the same manner as in Example 1, but 50 ml of purified water was used instead of 50 ml of a mixed solution containing the beta-glucosidase enzyme of Preparation Example 2.
- Example 1 used a fine powder to which the enzyme reaction and the fermentation process were continuously applied, and Example 2 performed far-infrared heat treatment before red ginseng grinding.
- Comparative Example 1 relates to coarsely pulverized red ginseng
- Comparative Example 2 is not treated with beta-glucosidase enzyme
- Comparative Example 3 is not subjected to the fermentation process by Monascus mycelium.
- red ginseng particles (Examples 1 and 2) fermented by beta-glucosidase enzyme reaction and Monascus mycelium were absorbed by water. And swelling power decreased, and water solubility increased.
- red ginseng powder which is coarsely ground or not treated with enzyme or fermentation, is not easily dispersed in a dispersion medium due to its relatively low water solubility.
- the water absorption or swelling power is related to the porous matrix structure formed by the polysaccharide chain, and when the size of the pulverized red ginseng powder particles is large, the matrix structure may be enlarged to increase the water absorption and swelling power of the powder. Therefore, coarsely pulverized red ginseng powder having a wide particle size and a uniform particle size distribution easily aggregates, and the finely ground powder has a small particle size and a uniform distribution so that external moisture cannot be easily absorbed, thereby increasing storage and dispersion stability. have.
- beta-glucosidase enzymatic reaction and the fermentation process with the Monascus mycelium make the matrix structure of the interior more compact and the particle shape uniform, so that the dispersion stability can be significantly increased.
- red ginseng powder dispersions were prepared according to Examples 1 to 3 and Comparative Examples 1 to 3, and each item was evaluated after the sample was sampled in small amounts. The results are shown in Table 2 below. . In particular, the evaluation of the sense of taste was observed by leaving the prepared red ginseng powder dispersion for 8 hours to the external layer separation.
- the red ginseng powder dispersion to which the beta-glucosidase enzyme reaction and the fermentation process by Monascus mycelium were continuously applied had a high satisfaction with texture, red ginseng aroma, and flavor, and the layer separation phenomenon despite being left for a long time. was hardly observed, and was evaluated as having excellent merchandise.
- the red ginseng powder dispersion of Example 2 in which the red ginseng extract was mixed was found to have almost no layer separation phenomenon and was excellent in dispersion stability.
- Comparative Example 2 in which the heat treatment step and the step of introducing the beta-glucosidase was omitted and the Comparative Example 3 in which the fermentation step was omitted are major saponins (Rb1, Rb2, Rc, Rd, Re, Rf, Rg1), and the content of minor saponins (Rd, Rg3, Rg2, Rh1, Rh2, F1) increased, but was analyzed to have a lower ginsenoside content than Examples 1 to 3 according to the present invention.
- Examples 1 to 3 as well as ginsenosides, such as Rh2, Rg3 and compound K, the content of ginsenoside metabolite, which is an easily absorbed form, has increased considerably, so that the body is easily absorbed and has an excellent health promoting effect. I think it will.
- the fermented red ginseng according to Examples 1 and 2 is not only excellent in ginsenosides content and excellent in functionality, but also better in taste and aroma than the existing red ginseng extract, thereby satisfying consumer's preference as a high quality red ginseng. have.
Abstract
Description
구분 | WAI | SW | WSI |
실시예 1 | 2.52±0.21 | 5.25±0.21 | 71.19±0.21 |
실시예 2 | 2.48±0.21 | 5.19±0.21 | 73.52±0.21 |
비교예 1 | 4.32±0.21 | 9.32±0.21 | 21.37±0.21 |
비교예 2 | 3.67±0.21 | 8.44±0.21 | 33.19±0.21 |
비교예 3 | 3.32±0.21 | 8.13±0.21 | 39.32±0.21 |
구분 | 맛(풍미) | 홍삼향 | 식감 | 미감 | 총평 |
실시예 1 | 4.3 | 4.2 | 4.3 | 4.5 | 4.2 |
실시예 2 | 4.4 | 4.5 | 4.3 | 4.6 | 4.3 |
실시예 3 | 4.5 | 4.8 | 4.3 | 4.4 | 4.4 |
비교예 1 | 2.6 | 2.5 | 2.7 | 2.3 | 2.5 |
비교예 2 | 3.3 | 3.1 | 3.2 | 2.9 | 3.3 |
비교예 3 | 3.2 | 2.9 | 3.1 | 3.5 | 3.1 |
구분 | 실시예 1 | 실시예 2 | 실시예 3 | 비교예 1 | 비교예 2 | 비교예 3 |
Rb1 | 35.19 | 37.21 | 36.21 | 23.21 | 25.62 | 27.15 |
Rb2 | 41.34 | 43.15 | 45.25 | 21.42 | 23.21 | 29.83 |
Rc | 27.16 | 28.59 | 27.36 | 20.84 | 24.54 | 28.51 |
Rd | 17.23 | 20.43 | 21.17 | 11.11 | 12.14 | 16.27 |
Re | 35.52 | 34.85 | 33.52 | 20.67 | 26.51 | 28.56 |
Rf | 24.12 | 27.13 | 25.93 | 22.32 | 25.17 | 27.54 |
Rg1 | 47.11 | 48.51 | 51.25 | 21.61 | 27.53 | 32.64 |
Rd | 32.53 | 33.34 | 35.87 | 20.12 | 20.53 | 25.61 |
Rg3 | 24.95 | 26.15 | 29.15 | 20.24 | 20.31 | 27.23 |
Rg2 | 15.23 | 16.18 | 18.36 | 20.31 | 20.29 | 26.53 |
Rh1 | 17.11 | 18.28 | 21.71 | 20.17 | 20.24 | 23.24 |
Rh2 | 28.19 | 29.14 | 32.37 | 10.05 | 10.09 | 14.64 |
F1 | 9.52 | 10.12 | 15.47 | 10.08 | 10.13 | 11.13 |
F2 | 13.12 | 14.61 | 17.13 | 10.16 | 10.21 | 11.35 |
Compound K | 6.12 | 6.62 | 8.13 | 10.31 | 10.34 | 11.21 |
Claims (32)
- (a) 홍삼을 분쇄하여 분말을 수득하는 단계;(b) 상기 분말을 베타 글루코시다제(β-Glucosidase)를 포함하는 혼합액에 투입하고 반응시키는 단계;(c) 상기 혼합액에 발효 균주를 접종하고 발효시키는 단계; 및(d) 상기 혼합액의 농도를 미리 정해진 범위로 조절하는 단계를 포함하는 발효 홍삼분말 분산액의 제조 방법.
- 제1항에 있어서,(e) 호모게나이저로 균질화하는 단계; 및(f) 40℃ 이하의 진공상태 하에서 저온 농축하는 단계를 더 포함하는 발효 홍삼분말 분산액의 제조 방법.
- 제1항에 있어서,상기 (a) 단계에서 상기 분말의 입도는 2 내지 20 마이크로미터(㎛)인 발효 홍삼분말 분산액의 제조 방법.
- 제1항에 있어서,상기 (a) 단계에서 상기 분쇄는 -20 내지 -5℃에서 수행되는 발효 홍삼분말 분산액의 제조 방법.
- 제1항에 있어서,상기 (a) 단계에서 상기 분말의 입도는 2 내지 20 마이크로미터(㎛)인 발효 홍삼분말 분산액의 제조 방법.
- 제1항에 있어서,상기 (b) 단계는 1.5 내지 4 바(bar)의 압력에서 1 내지 5시간 동안 수행되는 발효 홍삼분말 분산액의 제조 방법.
- 제1항에 있어서,상기 (b) 단계는 30 내지 45℃에서 수행되는 발효 홍삼분말 분산액의 제조 방법.
- 제1항에 있어서,상기 (b) 단계에서 상기 혼합액은 홍삼 추출물을 포함하는 발효 홍삼분말 분산액의 제조 방법.
- 제8항에 있어서,상기 홍삼 추출물은 탈염된 해양 심층수를 용매로 하여 제조된 발효 홍삼분말 분산액의 제조 방법.
- 제1항에 있어서,상기 (c) 단계에서 상기 발효 균주는 모나스커스 속(Monascus sp .), 락토바실러스 속(Lactobacillus sp .), 비피도박테리아 속(Bifidobacterium sp .), 프레보텔라 속(Prevotella sp .), 푸조박테리아 속(Fusobacterium sp .), 및 유박테리아 속(Eubacterium sp .) 균주로 이루어진 군에서 하나 이상 선택된 발효 홍삼분말 분산액의 제조 방법.
- 제10항에 있어서,상기 모나스커스 속 균주는 모나스커스 앵카(Monascus anka), 모나스커스 퍼푸레우스(Monascus purpureus), 모나스커스 필로서스(Monascus pilosus), 모나스커스 루버(Monascus ruber), 및 모나스커스 카올리앙(Monascus kaoliang)으로 이루어진 군에서 하나 이상 선택된 발효 홍삼분말 분산액의 제조 방법.
- 제1항에 있어서,상기 (c) 단계는 25 내지 35℃에서 3 내지 15일 동안 수행되는 발효 홍삼분말 분산액의 제조 방법.
- 제1항에 있어서,상기 (a) 단계 이전에 상기 홍삼을 열처리하는 단계를 더 포함하는 발효 홍삼분말 분산액의 제조 방법.
- 제13항에 있어서,상기 열처리는 상기 홍삼 표면에 수분을 공급하고 원적외선을 조사하는 발효 홍삼분말 분산액의 제조 방법.
- 제13항에 있어서,상기 열처리는 1 내지 4시간 동안 수행되는 발효 홍삼분말 분산액의 제조 방법.
- 제2항에 있어서,상기 (e) 단계는 200 내지 800 바(bar)의 압력에서 3회 이상 수행되는 발효 홍삼분말 분산액의 제조 방법.
- 제2항에 있어서,상기 (f) 단계는 1 내지 20kPa 압력의 진공 상태 하에서 수행되는 발효 홍삼분말 분산액의 제조 방법.
- (a) 홍삼을 90 내지 150 마이크로미터(㎛)의 입도로 조분쇄하는 단계;(b) 원적외선을 조사하는 단계;(c) 2 내지 20 마이크로미터(㎛)의 입도로 미분쇄하는 단계;(d) 상기 미분쇄된 홍삼에 베타 글루코시다제(β-Glucosidase)를 첨가하여 반응시키는 단계; 및(e) 발효 균주를 접종하고 발효시키는 단계를 포함하는 나노 홍삼분말의 제조 방법.
- 제18항에 있어서,상기 (a) 단계는 100 내지 500rpm의 저속 회전에 의해 수행되는 나노 홍삼분말의 제조 방법.
- 제18항에 있어서,상기 (b) 단계에서 상기 원적외선의 파장이 20 내지 40㎛인 나노 홍삼분말의 제조 방법.
- 제18항에 있어서,상기 (c) 단계에서 선회류를 형성하고 상기 홍삼 입자간 충돌을 유도하여 미분쇄하는 나노 홍삼분말의 제조 방법.
- 제21항에 있어서,상기 (c) 단계에서 초음파를 조사하여 입자간 충돌 빈도를 증가시키는 나노 홍삼분말의 제조 방법.
- 제22항에 있어서,상기 (c) 단계에서 상기 초음파의 진동수는 15KHz 내지 20KHz, 진폭은 5 내지 50㎛인 나노 홍삼분말의 제조 방법.
- 제21항에 있어서,상기 (c) 단계는 -20 내지 -5℃에서 수행되는 나노 홍삼분말의 제조 방법.
- 맞닿아 회전하는 하나 이상의 나선형 로울러를 포함하는 제1분쇄부;상기 홍삼에 원적외선을 조사하는 열처리부;선회류를 형성하고 상기 홍삼 입자간 충돌을 유도하여 홍삼을 미분쇄하는 제2분쇄부; 및상기 제2분쇄부에서 배출된 홍삼 입자를 포집하는 분리부를 포함하는 나노 홍삼분말의 제조 장치.
- 제25항에 있어서,상기 나선형 로울러는 100 내지 500rpm의 속도로 회전하는 나노 홍삼분말의 제조 장치.
- 제25항에 있어서,상기 열처리부는 파장이 20 내지 40㎛인 원적외선을 조사하는 나노 홍삼분말의 제조 장치.
- 제25항에 있어서,상기 제2분쇄부는 초음파를 조사하여 홍삼 입자간 충돌 빈도를 증가시키는 나노 홍삼분말의 제조 장치.
- 제28항에 있어서,상기 초음파의 진동수는 15KHz 내지 20KHz, 진폭은 5 내지 50㎛인 나노 홍삼분말의 제조 장치.
- 제25항에 있어서,상기 제2분쇄부는 저온의 공기를 공급하는 하나 이상의 냉각 장치를 포함하는 나노 홍삼분말의 제조 장치.
- 제30항에 있어서,상기 저온의 공기는 -20 내지 -5℃인 나노 홍삼분말의 제조 장치.
- 제25항에 있어서,상기 분리부는 내부의 압력을 감소시키는 진공펌프를 포함하는 나노 홍삼분말의 제조 장치.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017501701A JP6438111B2 (ja) | 2016-01-06 | 2016-07-11 | 乳化剤を含まずに紅参有効成分摂取率が極大化された発酵紅参粉末分散液の製造方法 |
US15/517,559 US20180263266A1 (en) | 2016-01-06 | 2016-07-11 | An apparatus for ultra-fine grinding of red ginseng, and a method for producing whole red ginseng extract and liquid with maximized nutrition absorptivity by enzyme fermentation |
DE112016006167.6T DE112016006167T5 (de) | 2016-01-06 | 2016-07-11 | Verfahren zur Herstellung einer fermentierten Pulverdispersion aus rotem Ginseng mit maximiertem Aufnahmeverhältnis, die keinen Emulgator enthält |
GB1700343.5A GB2552230A (en) | 2016-01-06 | 2016-07-11 | Apparatus for physically producing ulra-fine pulverized red ginseng powder,and method for producing red ginseng powder concentrate and red ginseng liquid thro |
CN201680002052.XA CN107427055B (zh) | 2016-01-06 | 2016-07-11 | 发酵红参粉末分散液制备方法及红参纳米粉末制备方法 |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2016-0001515 | 2016-01-06 | ||
KR10-2016-0001510 | 2016-01-06 | ||
KR10-2016-0001513 | 2016-01-06 | ||
KR1020160001518A KR101817558B1 (ko) | 2016-01-06 | 2016-01-06 | 물에 녹지 않는 홍삼의 유효성분 전체의 섭취를 가능하게 하고 세포벽 파괴를 통해 소화 흡수율을 극대화한 마이크로 프로세스 통홍삼 분말 제조 장치 |
KR1020160001510A KR101825059B1 (ko) | 2016-01-06 | 2016-01-06 | 생화학적 발효 및 효소 분해로 홍삼 유효성분의 소화 흡수 극대화를 위한 통홍삼액의 제조 방법 |
KR10-2016-0001518 | 2016-01-06 | ||
KR1020160001513A KR101825064B1 (ko) | 2016-01-06 | 2016-01-06 | 물리적 초미세분쇄로 홍삼 전체의 섭취가 가능하며, 유효성분의 소화 흡수 극대화를 위한 통홍삼 분말 및 통홍삼 분말 농축액의 제조 방법 |
KR1020160001515A KR101825067B1 (ko) | 2016-01-06 | 2016-01-06 | 물리적 초미세분쇄로 홍삼 전체의 섭취를 가능하게한 제조장치와 생화학적 발효, 효소분해를 통한 홍삼 유효성분의 소화 흡수 극대화를 위한 통홍삼액 제조 방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2017119565A1 true WO2017119565A1 (ko) | 2017-07-13 |
Family
ID=59274537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2016/007478 WO2017119565A1 (ko) | 2016-01-06 | 2016-07-11 | 물리적으로 초미세분쇄 홍삼분말을 제조하는 장치와 생화학적 발효, 효소분해를 통한 홍삼 유효성분의 소화 흡수 극대화를 위한 통홍삼 분말 농축액 및 통홍삼액 제조 방법 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20180263266A1 (ko) |
JP (1) | JP6438111B2 (ko) |
CN (1) | CN107427055B (ko) |
DE (1) | DE112016006167T5 (ko) |
WO (1) | WO2017119565A1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109536560A (zh) * | 2018-11-22 | 2019-03-29 | 华南协同创新研究院 | 一种提高人参水提取物中稀有皂苷含量的方法 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI675667B (zh) * | 2018-05-17 | 2019-11-01 | 蘇建樺 | 植物素組成物及其製造方法 |
CN109832622A (zh) * | 2019-04-19 | 2019-06-04 | 西北大学 | 一种绞股蓝超微粉及其制备方法 |
EP3991800A1 (en) * | 2020-10-28 | 2022-05-04 | Amorepacific Corporation | Ginseng powder, cosmetic composition comprising same and preparation method thereof |
CN112626157B (zh) * | 2021-01-12 | 2022-12-06 | 福建省农业科学院农业工程技术研究所 | 一种红曲糟抗热肽剂及其制备方法与应用 |
CA3220414A1 (en) * | 2021-05-28 | 2022-12-01 | Jie Qi | Extraction methods and apparatus |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100366125B1 (ko) * | 1999-12-31 | 2003-01-14 | 이영길 | 고춧가루의 가공방법 |
JP2003088773A (ja) * | 2001-09-20 | 2003-03-25 | Kurimoto Ltd | ジェットミル |
JP2004290738A (ja) * | 2003-03-25 | 2004-10-21 | Kurimoto Ltd | 気流式粉砕機 |
KR20110104621A (ko) * | 2010-03-17 | 2011-09-23 | 정종배 | 진세노사이드 증대를 위한 인삼발효 방법 |
KR20130034173A (ko) * | 2011-09-28 | 2013-04-05 | (주)지앤브이 | 진세노사이드의 함량을 증가시키는 인삼의 가공방법 및 그 가공물 |
KR101298809B1 (ko) * | 2010-07-30 | 2013-08-22 | 황인석 | 원적외선과 기류분쇄에 의한 위생 검정콩 활성 미분말 제조방법 |
KR20150055703A (ko) * | 2013-11-14 | 2015-05-22 | 주점숙 | 저분자 진세노사이드의 제조방법 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US210789A (en) * | 1878-12-10 | Improvement in fifth-wheel couplings | ||
CN1098882A (zh) * | 1993-08-17 | 1995-02-22 | 吴文才 | 多酶体系制备果菜汁和蛋白乳液的方法 |
CN1240390C (zh) * | 2002-01-30 | 2006-02-08 | 株式会社一和 | 生物转化人参组合物及其制备方法 |
KR20060024927A (ko) * | 2004-09-15 | 2006-03-20 | 씨제이 주식회사 | 기계적 분쇄법에 의한 미크론 사이즈 인삼 분말의제조방법 |
CA2606971A1 (en) * | 2006-10-18 | 2008-04-18 | In-Hwan Seong | Method for producing ginseng fruit and ginseng flower stalk with high content of ginsenoside |
KR100992800B1 (ko) * | 2010-05-14 | 2010-11-08 | 주식회사 지씨에이치앤피 | 미량의 진세노사이드 성분이 증가된 신규한 가공인삼 또는 가공인삼추출물의 제조방법 |
KR101287113B1 (ko) * | 2010-06-30 | 2013-07-17 | 삼성디스플레이 주식회사 | 증착 장치용 캐니스터 및 이를 이용한 증착 장치 |
KR101346626B1 (ko) * | 2011-02-08 | 2014-01-07 | 김재광 | 유산균 및 효소의 2단계 발효를 이용한 홍삼액의 제조방법 |
KR20130018534A (ko) * | 2011-08-01 | 2013-02-25 | 강원대학교산학협력단 | 특정 진세노사이드(Rg5, Rg3, Rk1, Rh2) 함량이 증가된 인삼, 홍삼 초미세 분말의 제조방법 |
KR101409761B1 (ko) * | 2012-06-20 | 2014-06-19 | 주식회사한국야쿠르트 | 효소전환과 유산균 발효를 이용한 화합물 k의 함량이 강화된 발효홍삼 농축액의 제조방법 및 그 제조방법에 의해 제조된 발효홍삼 농축액을 유효성분으로 함유하는 제품 |
KR101423116B1 (ko) * | 2012-12-26 | 2014-07-25 | 강원대학교산학협력단 | 저온 미분쇄기를 이용한 삼 배양근 초미세 분말의 제조 방법 및 그에 따른 삼 배양근 초미세 분말 |
-
2016
- 2016-07-11 WO PCT/KR2016/007478 patent/WO2017119565A1/ko active Application Filing
- 2016-07-11 DE DE112016006167.6T patent/DE112016006167T5/de not_active Ceased
- 2016-07-11 CN CN201680002052.XA patent/CN107427055B/zh not_active Expired - Fee Related
- 2016-07-11 JP JP2017501701A patent/JP6438111B2/ja not_active Expired - Fee Related
- 2016-07-11 US US15/517,559 patent/US20180263266A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100366125B1 (ko) * | 1999-12-31 | 2003-01-14 | 이영길 | 고춧가루의 가공방법 |
JP2003088773A (ja) * | 2001-09-20 | 2003-03-25 | Kurimoto Ltd | ジェットミル |
JP2004290738A (ja) * | 2003-03-25 | 2004-10-21 | Kurimoto Ltd | 気流式粉砕機 |
KR20110104621A (ko) * | 2010-03-17 | 2011-09-23 | 정종배 | 진세노사이드 증대를 위한 인삼발효 방법 |
KR101298809B1 (ko) * | 2010-07-30 | 2013-08-22 | 황인석 | 원적외선과 기류분쇄에 의한 위생 검정콩 활성 미분말 제조방법 |
KR20130034173A (ko) * | 2011-09-28 | 2013-04-05 | (주)지앤브이 | 진세노사이드의 함량을 증가시키는 인삼의 가공방법 및 그 가공물 |
KR20150055703A (ko) * | 2013-11-14 | 2015-05-22 | 주점숙 | 저분자 진세노사이드의 제조방법 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109536560A (zh) * | 2018-11-22 | 2019-03-29 | 华南协同创新研究院 | 一种提高人参水提取物中稀有皂苷含量的方法 |
CN109536560B (zh) * | 2018-11-22 | 2021-07-30 | 华南协同创新研究院 | 一种提高人参水提取物中稀有皂苷含量的方法 |
Also Published As
Publication number | Publication date |
---|---|
DE112016006167T5 (de) | 2018-09-27 |
CN107427055B (zh) | 2021-09-17 |
US20180263266A1 (en) | 2018-09-20 |
CN107427055A (zh) | 2017-12-01 |
JP2018508180A (ja) | 2018-03-29 |
JP6438111B2 (ja) | 2018-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2017119565A1 (ko) | 물리적으로 초미세분쇄 홍삼분말을 제조하는 장치와 생화학적 발효, 효소분해를 통한 홍삼 유효성분의 소화 흡수 극대화를 위한 통홍삼 분말 농축액 및 통홍삼액 제조 방법 | |
CN101962596A (zh) | 同步制备核桃油和核桃蛋白肽的方法 | |
KR101825064B1 (ko) | 물리적 초미세분쇄로 홍삼 전체의 섭취가 가능하며, 유효성분의 소화 흡수 극대화를 위한 통홍삼 분말 및 통홍삼 분말 농축액의 제조 방법 | |
CN113208120B (zh) | 一种皮克林乳化性纳米柑橘皮膳食纤维的制备方法及其应用 | |
KR102260026B1 (ko) | 귀뚜라미 가압증숙 및 효소처리물을 함유하는 면역조절용 조성물 | |
KR101825067B1 (ko) | 물리적 초미세분쇄로 홍삼 전체의 섭취를 가능하게한 제조장치와 생화학적 발효, 효소분해를 통한 홍삼 유효성분의 소화 흡수 극대화를 위한 통홍삼액 제조 방법 | |
KR101525533B1 (ko) | 미생물 발효액을 사용하여 제조한 옻나무 추출물을 이용한 발효곡물의 제조방법 | |
KR101817558B1 (ko) | 물에 녹지 않는 홍삼의 유효성분 전체의 섭취를 가능하게 하고 세포벽 파괴를 통해 소화 흡수율을 극대화한 마이크로 프로세스 통홍삼 분말 제조 장치 | |
KR20110010593A (ko) | 진세노사이드 추출 효율 향상을 위한 인삼의 추출방법 | |
JP5101746B1 (ja) | ニンニク破砕物、活性酸素消去剤、及びニンニク破砕物の製造方法 | |
CN108185413B (zh) | 食用菌提取液的制备方法及食用菌提取液及利用其所调配的复合物 | |
CN115433290B (zh) | 羊栖菜多糖的提取方法和基于此的羊栖菜降解多糖的制备方法及羊栖菜降解多糖的应用 | |
KR101825059B1 (ko) | 생화학적 발효 및 효소 분해로 홍삼 유효성분의 소화 흡수 극대화를 위한 통홍삼액의 제조 방법 | |
CN115232223B (zh) | 一种从脱脂豆粕中高效提取大豆低聚糖的方法 | |
KR20190053607A (ko) | 고압 분쇄추출 공정을 이용한 아로니아 추출물의 제조방법 및 이에 의해 제조된 아로니아 추출물을 유효성분으로 함유하는 면역 증진용 약학 조성물 | |
RU2443781C1 (ru) | Способ производства этилового спирта из зернового сырья | |
KR101061258B1 (ko) | 진세노사이드 추출 효율 향상을 위한 인삼 분말의 파쇄방법 | |
CN113425751B (zh) | 一种灵芝提取物的制备方法 | |
JPS62259564A (ja) | マンネンタケエキス粉末の製造方法 | |
KR20180040342A (ko) | 가바쌀 현미효소의 제조방법 | |
KR101803263B1 (ko) | 항염, 항알러지 및 아토피 피부 개선 효과를 가지는 수수 발효물, 이의 제조방법 및 이의 화장료 조성물 | |
KR101860010B1 (ko) | 효소 처리 및 초고압 균질화 공정을 이용한 금강송 추출물의 제조방법 | |
GB2552230A (en) | Apparatus for physically producing ulra-fine pulverized red ginseng powder,and method for producing red ginseng powder concentrate and red ginseng liquid thro | |
CN117426518A (zh) | 利用益生菌改善肠道菌群的组合物及其制备方法 | |
CN114468114A (zh) | 微波辅助酶法结合气流超微粉碎制备大豆分离蛋白的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref document number: 201700343 Country of ref document: GB Kind code of ref document: A Free format text: PCT FILING DATE = 20160711 |
|
ENP | Entry into the national phase |
Ref document number: 2017501701 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 15517559 Country of ref document: US |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16883951 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 112016006167 Country of ref document: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 29.10.2018) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 16883951 Country of ref document: EP Kind code of ref document: A1 |